Showing results (491-500 of 512) with videos related to
Sort By:
Pageof 52
Gastroenterology|November 3, 2015
Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative ColitisGaik W Tew, Jason A Hackney, Deena Gibbons, et al.Gut|April 27, 2021
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBDNicholas A Kennedy, Simeng Lin, James R Goodhand, et al.Journal of Crohn'S & Colitis|September 2, 2021
Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated PatientsNeil Chanchlani, Simeng Lin, Desmond Chee, et al.Alimentary Pharmacology & Therapeutics|October 7, 2014
Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patientsN A Kennedy, R Kalla, B Warner, et al.Journal of Crohn'S & Colitis|June 5, 2020
Clinical Features and Genetic Risk of Demyelination Following Anti-TNF TreatmentSimeng Lin, Harry D Green, Peter Hendy, et al.The Lancet. Gastroenterology & Hepatology|March 3, 2019
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort studyNicholas A Kennedy, Graham A Heap, Harry D Green, et al.Journal of Crohn'S & Colitis|December 28, 2018
Current Practices in Ileal Pouch Surveillance for Patients With Ulcerative Colitis: A Multinational, Retrospective Cohort StudyMark A Samaan, Katrina Forsyth, Jonathan P Segal, et al.The Lancet. Gastroenterology & Hepatology|February 10, 2024
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trialJames O Lindsay, Daniel Hind, Lizzie Swaby, et al.The Lancet. Gastroenterology & Hepatology|February 6, 2022
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control studyJames L Alexander, Nicholas A Kennedy, Hajir Ibraheim, et al.Ebiomedicine|January 1, 2025
Evaluation of intestinal biopsy tissue preservation methods to facilitate large-scale mucosal microbiota researchNicola J Wyatt, Hannah Watson, Gregory R Young, et al.Pageof 52